#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4376	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2347	351.0	0	.	n	.	0	C1450T	SNP	1450	1450	C	1843	1843	T	494	T,C	230,75	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4376	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2347	351.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1577	1577	C	458	C,T	293,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	10042	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3342	548.4	0	.	n	.	0	T695C	SNP	695	695	T	910	910	C	561	C	355	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	10042	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3342	548.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1552	1552	A	488	A	310	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	10042	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3342	548.4	0	.	n	.	0	A1638G	SNP	1638	1638	A	1853	1853	G	461	G,T	305,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	10042	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3342	548.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2186	2186	C	557	C,T	347,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	10042	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3342	548.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2260	2260	A	594	A	376	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	10042	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3342	548.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2812	2812	C	709	C,T	466,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	10042	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3342	548.4	0	HET	.	.	.	C2525T,A	.	2525	2525	C	2740	2740	C	684	C,T,A	360,83,1	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	972	folP	855	855	100.0	folP.l15.c4.ctg.1	1595	114.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1031	1033	AGC	142;143;146	A;G;C	98;99;100	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	2084	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3129	125.7	1	SNP	p	S91F	1	.	.	271	273	TTC	436	438	TTC	151;151;151	T;T;C	100;99;101	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	2084	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3129	125.7	1	SNP	p	G95N	0	.	.	283	285	GGC	448	450	GGC	168;168;169	G,T,C;G,T;C	111,1,1;113,1;114	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	2084	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3129	125.7	1	SNP	p	D95G	1	.	.	283	285	GGC	448	450	GGC	168;168;169	G,T,C;G,T;C	111,1,1;113,1;114	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	606	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1487	79.3	1	SNP	p	G45D	0	.	.	133	135	GGC	440	442	GGC	171;173;172	G;G;C	102;100;99	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	450	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	615	125.5	0	.	n	.	0	A197.	DEL	197	197	A	371	371	A	194	A	115	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1936	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2867	125.3	1	SNP	p	D86N	0	.	.	256	258	GAC	401	403	GAC	166;167;170	G,T;A,C;C	102,1;102,1;111	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1936	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2867	125.3	1	SNP	p	R87I	0	.	.	259	261	CGT	404	406	CGT	168;168;171	C;G,C;T,A	111;107,1;110,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1936	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2867	125.3	1	SNP	p	S87R	1	.	.	259	261	CGT	404	406	CGT	168;168;171	C;G,C;T,A	111;107,1;110,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1936	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2867	125.3	1	SNP	p	R87W	0	.	.	259	261	CGT	404	406	CGT	168;168;171	C;G,C;T,A	111;107,1;110,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1936	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2867	125.3	1	SNP	p	S88P	0	.	.	262	264	TCC	407	409	TCC	171;171;171	T,G;C;C	115,1;112;117	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1872	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2650	134.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1436	1438	GGC	137;137;138	G;G;C	96;97;95	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.41.001	penA.41.001	1	1	27	1578	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2520	115.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1372	1374	GCA	183;188;188	G;C;A	119;120;120	penA.41.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1578	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2520	115.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1375	1377	ATC	190;189;191	A;T;C	121;121;122	penA.41.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1578	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2520	115.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1387	1389	GTG	193;193;193	G,C;T,G,A;G	124,1;119,4,1;125	penA.41.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1578	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2520	115.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1387	1389	GTG	193;193;193	G,C;T,G,A;G	124,1;119,4,1;125	penA.41.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1578	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2520	115.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1891	1893	ACC	144;144;141	A;C;C	93;97;96	penA.41.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1578	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2520	115.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1945	1947	GCG	122;121;121	G;C;G	82;74;77	penA.41.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1578	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2520	115.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1945	1947	GCG	122;121;121	G;C;G	82;74;77	penA.41.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1578	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2520	115.1	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2068	2070	AGC	121;123;128	A,C;G,C;C	83,1;87,1;91	penA.41.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1578	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2520	115.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2077	2079	GGC	113;113;113	G;G;C,G	78;78;78,1	penA.41.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1578	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2520	115.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2095	2097	CCG	111;110;110	C,G;C;G,C	73,2;76;74,1	penA.41.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	2268	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3055	133.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1626	1628	CCG	98;98;98	C,G;C;G	62,2;67;61	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	820	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1824	86.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	548	548	C	80	C	46	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	818	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1872	81.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	624	626	GAA	135;128;128	G;A;A	88;83;83	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	818	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1872	81.2	1	SNP	p	D121N	1	D121N	NONSYN	361	363	GAC	873	875	AAC	102;103;103	A;A;C	67;69;69	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	818	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1872	81.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	912	914	GAT	102;104;104	G;A;T	68;68;69	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	818	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1872	81.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1035	1037	TCA	108;108;106	T,G;C;A,C	66,1;67;64,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	818	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1872	81.2	0	.	p	.	0	A218I	NONSYN	652	654	GCC	1164	1166	ATC	130;134;135	A;T,G;C	80;82,1;84	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	818	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1872	81.2	0	.	p	.	0	R258H	NONSYN	772	774	CGT	1284	1286	CAT	107;104;104	C;A,C;T	71;68,1;69	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	818	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1872	81.2	0	.	p	.	0	S295G	NONSYN	883	885	AGT	1395	1397	GGT	120;121;109	G;G;T	75;75;69	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	818	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1872	81.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1494	1496	GCA	89;88;84	G;C;A	63;61;60	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	818	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1872	81.2	1	SNP	p	G120K	1	.	.	358	360	AAG	870	872	AAG	99;99;102	A;A,G;G	66;65,1;68	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2392	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4775	93.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	174	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1105	30.6	1	SNP	p	V57M	1	.	.	169	171	ATG	612	614	ATG	63;61;61	A;T,G;G	41;39,1;40	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
